Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists

PloS One
V G MaltarolloK M Honorio

Abstract

Peroxisome proliferator-activated receptors (PPARs) are involved in the control of carbohydrate and lipid metabolism and are considered important targets to treat diabetes mellitus and metabolic syndrome. The available PPAR ligands have several side effects leading to health risks justifying the search for new bioactive ligands to activate the PPAR subtypes, in special PPARδ, the less studied PPAR isoform. Here, we used a structure-based virtual screening protocol in order to find out new PPAR ligands. From a lead-like subset of purchasable compounds, we identified 5 compounds with potential PPAR affinity and, from preliminary in vitro assays, 4 of them showed promising biological activity. Therefore, from our in silico and in vitro protocols, new PPAR ligands are potential candidates to treat metabolic diseases.

References

Sep 5, 1991·Journal of Molecular Biology·B K Shoichet, I D Kuntz
Oct 25, 1982·Journal of Molecular Biology·I D KuntzT E Ferrin
Dec 1, 1995·Journal of Computer-aided Molecular Design·G JonesR C Glen
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·H E XuT M Willson
Jan 31, 2002·Annual Review of Medicine·Joel Berger, David E Moller
May 11, 2002·Nature Reviews. Cancer·John R Masters
Aug 29, 2002·Journal of Computer-aided Molecular Design·Renxiao WangShaomeng Wang
Oct 29, 2002·Proteins·J Willem M NissinkRobin Taylor
Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
May 25, 2004·Journal of Chemical Information and Computer Sciences·Romano T KroemerPieter F W Stouten
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Jul 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexander W Schüttelkopf, Daan M F van Aalten
Jun 7, 2005·Proteins·Jason C ColeRobin Taylor
Jun 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yong LiH Eric Xu
Oct 26, 2005·Bioorganic & Medicinal Chemistry Letters·Raquel PereiraAngel R de Lera
Aug 1, 1981·Plant Physiology·B A Zilinskas, R E Glick
Jun 6, 2006·Bioorganic & Medicinal Chemistry Letters·Robert EppleShin-Shay Tian
Jul 25, 2006·Proteins·Sérgio Filipe SousaMaria João Ramos
Aug 26, 2006·Bioorganic & Medicinal Chemistry Letters·Robert EppleShin-Shay Tian
Nov 30, 2006·Pharmacological Reviews·Liliane MichalikWalter Wahli
Dec 13, 2006·Journal of Medicinal Chemistry·Niu HuangJohn J Irwin
Dec 15, 2006·The Journal of Pharmacology and Experimental Therapeutics·Akinori IwashitaNobuya Matsuoka
Feb 14, 2007·Journal of Chemical Information and Modeling·Reiji Teramoto, Hiroaki Fukunishi
Apr 13, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Pitchai BalakumarManjeet Singh
Jun 15, 2007·Bioorganic & Medicinal Chemistry Letters·Ingrid PetterssonPer Sauerberg
Jul 3, 2007·Bioorganic & Medicinal Chemistry Letters·Philip WickensManami Tsutsumi
Oct 17, 2007·Structure·John B BruningPatrick R Griffin
Dec 1, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Yanbo FanNanping Wang
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Aug 30, 2008·Bioorganic & Medicinal Chemistry Letters·Barry G ShearerTimothy M Willson
Jan 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dean R ArtisJames F Tobin
May 26, 2009·Bioorganic & Medicinal Chemistry Letters·Richard V ConnorsPeter Coward
Jul 23, 2009·Acta Crystallographica. Section D, Biological Crystallography·Takuji OyamaKosuke Morikawa

❮ Previous
Next ❯

Citations

Oct 6, 2015·Trends in Pharmacological Sciences·Sascha Sauer
Apr 27, 2019·Expert Opinion on Drug Discovery·Olivia Slater, Maria Kontoyianni
Feb 8, 2020·Journal of Cellular and Molecular Medicine·Liwei WuJianye Wu
Jun 19, 2016·Chemical Biology & Drug Design·Jun ZhangRun-Ling Wang
Mar 30, 2017·PPAR Research·Melody ChiuTerry D Hinds

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

GROMACS
GOLD
PRODRG2 Server
Gromos
UCSF DOCK
ZINC
- docking
Surflex
Sybyl
- Dock

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.